---
figid: PMC3828559__fonc-03-00281-g001
figlink: /pmc/articles/PMC3828559/figure/F1/
number: F1
caption: RAS-RAF pathway and immunohistochemical staining of colorectal cancer specimens
  with BRAF V600E mutation specific monoclonal antibody. (A) Strong immunopositivity
  in cancer cells with a BRAF V600E mutation. (B) No staining of cancer cells in a
  specimen without BRAF V600E mutation. Original magnifications are 200×. (C) Schematic
  RAS-RAF pathway (orange boxes) and inhibitors of components of this pathway (blue
  boxes). Arrows indicate an activation process, and blocked arrows an inhibition
  process.
pmcid: PMC3828559
papertitle: 'Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF.'
reftext: Alexandra Thiel, et al. Front Oncol. 2013;3:281.
pmc_ranked_result_index: '36166'
pathway_score: 0.8021713
filename: fonc-03-00281-g001.jpg
figtitle: RAS-RAF pathway and immunohistochemical staining of colorectal cancer specimens
  with BRAF V600E mutation specific monoclonal antibody
year: '2013'
organisms: Homo sapiens
ndex: 12b831ed-dea6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3828559__fonc-03-00281-g001.html
  '@type': Dataset
  description: RAS-RAF pathway and immunohistochemical staining of colorectal cancer
    specimens with BRAF V600E mutation specific monoclonal antibody. (A) Strong immunopositivity
    in cancer cells with a BRAF V600E mutation. (B) No staining of cancer cells in
    a specimen without BRAF V600E mutation. Original magnifications are 200×. (C)
    Schematic RAS-RAF pathway (orange boxes) and inhibitors of components of this
    pathway (blue boxes). Arrows indicate an activation process, and blocked arrows
    an inhibition process.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - MAPK3
  - MAP2K2
  - KRAS
  - MAPK1
  - EGFR
  - BRAF
  - Trametinib
  - Dabrafenib
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1/2H
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals:
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Dabrafenib
  source: MESH
  identifier: C561627
diseases: []
figid_alias: PMC3828559__F1
redirect_from: /figures/PMC3828559__F1
figtype: Figure
---
